Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;8(21):1350.
doi: 10.21037/atm-20-4873.

Factors associated with bronchiectasis in Korea: a national database study

Affiliations

Factors associated with bronchiectasis in Korea: a national database study

Bumhee Yang et al. Ann Transl Med. 2020 Nov.

Abstract

Background: Many important clinical features of bronchiectasis have been reported. However, the factors were evaluated using a specific disease cohort. Thus, clinical factors associated with bronchiectasis have not been well assessed in comparison to the general population. The aim of this study was to evaluate the factors associated with bronchiectasis using a national representative database.

Methods: We conducted a cross-sectional study using data from the Korean National Health and Nutrition Examination Survey 2007-2009. To evaluate factors associated with bronchiectasis, a multivariable logistic analysis was used with adjustment for demographic and socioeconomic factors.

Results: In the present study, the prevalence of bronchiectasis was 0.4%. Compared with subjects without bronchiectasis, subjects with bronchiectasis were older (55.1 vs. 44.4 years, P<0.001) and had lower body mass index (BMI) (23.2 vs. 24.2 kg/m2, P<0.001). The proportions of low family income (70.5% vs. 40.2%, P<0.001) and low educational level (less than high school) (85.3% vs. 70.6%, P=0.041) were higher in subjects with bronchiectasis than in subjects without bronchiectasis. Regarding comorbidities, subjects with bronchiectasis were more likely to have asthma (17.8% vs. 2.9%, P<0.001), previous history of pulmonary tuberculosis (TB) (43.5% vs. 5.0%, P<0.001), osteoporosis (19.1% vs. 7.8%, P=0.002), and depression (9.3% vs. 3.0%, P=0.015) compared with subjects without bronchiectasis. In addition, subjects with bronchiectasis had more respiratory symptoms and poorer quality of life measured using the EuroQoL five dimensions questionnaire (EQ-5D) index (0.87 vs. 0.93, P<0.001) than subjects without bronchiectasis. In multivariable logistic regression analysis, low family income (adjusted odds ratio, OR =3.83, 95% confidence interval, CI: 1.46-10.03), asthma (adjusted OR =3.73, 95% CI: 1.29-10.79), pulmonary TB (adjusted OR =7.88, 95% CI: 2.65-23.39), and the presence of airflow limitation (adjusted OR =2.98, 95% CI: 1.01-8.98) were independently associated with bronchiectasis.

Conclusions: Subjects with bronchiectasis suffered from more respiratory symptoms with limited physical activity and poorer quality of life than the general population. Factors independently associated with bronchiectasis were lower family income and comorbid pulmonary conditions, such as previous pulmonary TB, asthma, and airflow limitation.

Keywords: Epidemiologic factors; National Health and Nutritional Examination Survey; bronchiectasis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-4873). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The prevalence of bronchiectasis in subjects with TB, asthma, and airflow limitation based on Korean NHANES 2007–2009 data. The prevalence is presented as weighted percentage (95% CI). *, airflow limitation was defined as pre-bronchodilator FEV1/FVC <0.7. TB, tuberculosis; NHANES, National Health and Nutrition Examination Survey; CI, confidence interval; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
Figure 2
Figure 2
Venn diagram showing the rate of TB, asthma, and airflow limitation in subjects with bronchiectasis. *, airflow limitation was defined as pre-bronchodilator FEV1/FVC <0.7. TB, tuberculosis; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.

Similar articles

Cited by

References

    1. Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Primers 2018;4:45. 10.1038/s41572-018-0042-3 - DOI - PubMed
    1. Choi H, Yang B, Nam H, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54:1900194. 10.1183/13993003.00194-2019 - DOI - PubMed
    1. Ringshausen FC, de Roux A, Pletz MW, et al. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One 2013;8:e71109. 10.1371/journal.pone.0071109 - DOI - PMC - PubMed
    1. Visser SK, Bye PTP, Fox GJ, et al. Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry. Respir Med 2019;155:97-103. 10.1016/j.rmed.2019.07.016 - DOI - PubMed
    1. Aksamit TR, O'Donnell AE, Barker A, et al. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry. Chest 2017;151:982-92. 10.1016/j.chest.2016.10.055 - DOI - PMC - PubMed